The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

The FDA on Thursday approved Fabhalta (iptacopan) to treat complement 3 glomerulopathy (CG3), a progressive, ultrarare kidney ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

This causes salt and water accumulation, further increasing blood pressure and potentially leading to severe complications such as stroke or kidney damage. Hypertension causes thickening of Small ...

Certain foods are bad for your health if you have kidney disease. Healthy kidneys regulate the body’s mineral and protein levels. But kidney disease causes progressive damage that interferes with ...

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...

AstraZeneca (AZ) and Ionis Pharmaceuticals’ Wainzua (eplontersen) has been approved by the European Commission (EC) to treat a subset of adults with the rare disease hereditary transthyretin-mediated ...

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons—as a therapeutic target for Alzheimer's disease. But anti-amyloid ...

Kenyans are yet to reap the benefits of a Sh3.6 billion East Africa Kidney Institute Centre of Excellence. Despite heavy investment in infrastructure and resources, the project has failed to take off, ...

Chronic kidney disease (CKD) refers to gradual kidney damage that reduces the kidneys’ ability to filter blood. CKD progresses through stages 1 to 5. Stage 4 CKD is the final stage before ...